AllianceBernstein’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $350K | Hold |
|
|||||
|
2025
Q2 | $156K | Buy |
|
|||||
|
2025
Q1 | $152K | Hold |
|
|||||
|
2024
Q4 | $260K | Hold |
|
|||||
|
2024
Q3 | $196K | Hold |
|
|||||
|
2024
Q2 | $326K | Buy |
|
|||||
|
2024
Q1 | $350K | Sell |
|
|||||
|
2023
Q4 | $519K | Hold |
|
|||||
|
2023
Q3 | $583K | Sell |
|
|||||
|
2023
Q2 | $796K | Sell |
|
|||||
|
2023
Q1 | $42M | Sell |
|
|||||
|
2022
Q4 | $49.2M | Buy |
|
|||||
|
2022
Q3 | $58.7M | Buy |
|
|||||
|
2022
Q2 | $41.1M | Sell |
|
|||||
|
2022
Q1 | $75.1M | Buy |
|
|||||
|
2021
Q4 | $91.1M | Buy |
|
|||||
|
2021
Q3 | $73.8M | Buy |
|
|||||
|
2021
Q2 | $62.3M | Buy |
|
|||||
|
2021
Q1 | $61.3M | Sell |
|
|||||
|
2020
Q4 | $81.8M | Buy |
|
|||||
|
2020
Q3 | $82.7M | Buy |
|
|||||
|
2020
Q2 | $73.5M | Buy |
|
|||||
|
2020
Q1 | $52.3M | Buy |
|
|||||
|
2019
Q4 | $39.2M | Buy |
|
|||||
|
2019
Q3 | $11.2M | Buy |
|
|||||
|
2019
Q2 | $2M | Buy |
|
|||||
|
2019
Q1 | $971K | Hold |
|
|||||
|
2018
Q4 | $644K | Hold |
|
|||||
|
2018
Q3 | $1.18M | Buy |
|
|||||
|
2018
Q2 | $966K | Buy |
|
|||||
|
2018
Q1 | $384K | Buy |
|
|||||
|
2017
Q4 | $253K | Hold |
|
|||||
|
2017
Q3 | $383K | Sell |
|
|||||
|
2017
Q2 | $524K | Buy |
|
|||||
|
2017
Q1 | $622K | Sell |
|
|||||
|
2016
Q4 | $927K | Hold |
|
|||||
|
2016
Q3 | $882K | Hold |
|
|||||
|
2016
Q2 | $556K | Buy |
|
|||||
|
2016
Q1 | $599K | Sell |
|
|||||
|
2015
Q4 | $783K | Hold |
|
|||||
|
2015
Q3 | $684K | Buy |
|
|||||
|
2015
Q2 | $962K | Buy |
|
|||||
|
2015
Q1 | $199K | Buy |
|